Dialysis Filter Life in COVID-19: Early Lessons from the Pandemic.
作者信息
Portales-Castillo Ignacio, Allegretti Andrew S
机构信息
Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
Kidney360. 2020 Dec 31;1(12):1334-1336. doi: 10.34067/KID.0006212020.
Abstract
摘要
相似文献
1
Dialysis Filter Life in COVID-19: Early Lessons from the Pandemic.
Kidney360. 2020 Dec 31;1(12):1334-1336. doi: 10.34067/KID.0006212020.
2
Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project.
Crit Care. 2012 Oct 24;16(5):R205. doi: 10.1186/cc11835.
3
Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Trials. 2020 Nov 11;21(1):920. doi: 10.1186/s13063-020-04814-0.
4
Filter clotting with continuous renal replacement therapy in COVID-19.
J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7.
5
Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.
Blood Purif. 2021;50(2):150-160. doi: 10.1159/000509677. Epub 2020 Jul 14.
6
Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure.
Am J Kidney Dis. 1991 Oct;18(4):451-8. doi: 10.1016/s0272-6386(12)80113-2.
7
CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial.
PLoS One. 2023 Jan 11;18(1):e0278550. doi: 10.1371/journal.pone.0278550. eCollection 2023.
8
Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
Crit Care Med. 2004 Dec;32(12):2437-42. doi: 10.1097/01.ccm.0000147687.06808.92.
9
Acute Peritoneal Dialysis During the COVID-19 Pandemic at Bellevue Hospital in New York City.
Kidney360. 2020 Oct 16;1(12):1345-1352. doi: 10.34067/KID.0005192020. eCollection 2020 Dec 31.
10
Phenytoin removal by continuous venovenous hemofiltration.
Ann Pharmacother. 2013 Sep;47(9):1218-22. doi: 10.1177/1060028013503131.
引用本文的文献
1
Coagulation Risk Predicting in Anticoagulant-Free Continuous Renal Replacement Therapy.
Blood Purif. 2024;53(11-12):916-927. doi: 10.1159/000540695. Epub 2024 Aug 12.
2
Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases.
Case Rep Nephrol. 2021 Mar 12;2021:5575928. doi: 10.1155/2021/5575928. eCollection 2021.
本文引用的文献
1
Dialysis Filter Life, Anticoagulation, and Inflammation in COVID-19 and Acute Kidney Injury.
Kidney360. 2020 Oct 20;1(12):1426-1431. doi: 10.34067/KID.0004322020. eCollection 2020 Dec 31.
2
Filter clotting with continuous renal replacement therapy in COVID-19.
J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7.
3
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):124-126. doi: 10.2215/CJN.08430520. Epub 2020 Sep 17.
4
Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.
Am J Kidney Dis. 2020 Nov;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005. Epub 2020 Jul 28.
5
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
6
Bleeding and Bleeding Risk in COVID-19.
Semin Thromb Hemost. 2020 Oct;46(7):815-818. doi: 10.1055/s-0040-1713434. Epub 2020 Jun 8.
7
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.
N Engl J Med. 2020 May 28;382(22):2147-2156. doi: 10.1056/NEJMcpc2002418. Epub 2020 May 13.
8
COVID-19 and its implications for thrombosis and anticoagulation.
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
9
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
Int J Lab Hematol. 2020 Jun;42 Suppl 1(Suppl 1):19-20. doi: 10.1111/ijlh.13230.
10
Thromboinflammation and the hypercoagulability of COVID-19.
J Thromb Haemost. 2020 Jul;18(7):1559-1561. doi: 10.1111/jth.14849. Epub 2020 May 26.
Zotero 插件